Relation between insulin-like growth factor-I concentrations, osteoarthritis, bone density, and fractures in the general population: The Chingford study

Annals of the Rheumatic Diseases

Volumn 55, Issue 12, 1996, Pages 870-874

  Lloyd, Mark E ^a   Hart, Deborah J ^a   Nandra, Dalbir ^a   McAlindon, Timothy E ^a   Wheeler, Michael ^a   Doyle, David V ^b   Spector, Tim D ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

^b WHIPPS CROSS UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

SOMATOMEDIN C;

ADULT; ARTICLE; BONE DENSITY; CONTROLLED STUDY; FEMALE; FRACTURE; HUMAN; MAJOR CLINICAL STUDY; OSTEOARTHRITIS; PHOTON ABSORPTIOMETRY; PRIORITY JOURNAL;

EID: 0030467108     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.55.12.870     Document Type: Article

References (29)

1. Morales TI, Hascall VC. Factors involved in the regulation of proteoglycan metabolism in articular cartilage. Arthritis Rheum 1989;32:1197-201.
2. Froesch ER, Schmid C, Scwander J, Zapf J. Actions of insulin-like growth factors. Annu Rev Physiol 1985; 47:443-67.
3. Florini JR. Hormonal control of muscle bulk. Muscle Nerve 1987;10:577-98.
4. Kelly PJ, Eisman JA, Stuart MC, Pocock NA, Sambrook PN, Gwinn TH. Somatomedin-C, physical fitness and bone density. J Clin Endocrinol Metab 1990;70:718-23.
5. Rudman D, Kutner MH, Rogers CM, Lubin MF, Fleming GA, Bain RP. Impaired growth hormone in the adult population: relationship to age and adiposity. J Clin Invest 1981;67:1361-9.
6. Rudman D, Feller AG, Hoskote SN, Gergans GA, Lalitha PY, Goldberg AF, et al. Effects of growth hormone in men aged over 60 years old. N Engl J Med 1990;323:1-6.
7. Schouten JSAG, Van den Ouweland FA, Valkenburg HA, Lamberts SWJ. Insulin-like growth factor-1: a prognostic factor of knee osteoarthritis. Br J Rheumatol 1993;32:274-80.
8. Denko CW, Boja B, Moskowitz RW. Growth promoting peptides in osteoarthritis: insulin, insulin-like growth factor-1, growth hormone. J Rheumatol 1990;17:1217-21.
9. Hochberg MC, Lethbridge-Cejku M, Scott WW, Reichle R, Plato CC, Tobin JD Serum concentrations of insulin-like growth factor 1 in subjects with osteoarthritis of the knee. Data from the Baltimore Longitudinal Study of Ageing. Arthritis Rheum 1994;37:1177-80.
10. McAlindon TE, Teale JD, Dieppe PA. Levels of insulin related growth factor 1 in osteoarthritis of the knee. Ann Rheum Dis 1993;52:229-31.
11. Wuster C, Blum WF, Schlemilch S, Ranke MB, Ziegler R. Decreased serum concentrations of insulin-tike growth factors and IGF binding protein 3 in osteoporosis. J Intern Med 1993;234:249-55.
12. Pun KK, Lau P, Wong FHW, Cheng CL, Pun WK, Chow SP, et al. 25-Hydroxycholecalciferol and insulin like growth factor 1 are determinants of serum concentration of osteocalcin in elderly subjects with and without spinal fractures. Bone 1990;11:397-400.
13. Ljunghall S, Johansson AG, Burman P, Lindh E, Karlsson FA. Low plasma concentrations of insulin-like growth factor I (IGF-I) in male patients with idiopathic osteoporosis. J Intern Med 1992;232:59-64.
14. Reed BY, Zerwekh JE, Sakhaee K, Breslau NA, Gottschalk F, Pak C. Serum IGF 1 is low and correlated with osteoblastic surface in idiopathic osteoporosis. J Bone Miner Res 1995;10:1218-24.
15. Bennett AE, Wahner HW, Riggs BL, Hintz RL. Insulin-like growth factors 1 and 2: ageing and bone density in women. J Clin Endocrinol Metab 1984;59:701-4.
16. Hart DJ, Spector TD. The relationship of obesity, fat distribution and osteoarthritis in women in the general population: the Chingford population. J Rheumatol 1993;20:331-5.
17. Spector TD, Cooper C, Cushnaghan J, Hart DJ, Dieppe PA. A radiographic atlas of knee osteoarthritis. London: Springer Verlag, 1992.
18. Spector TD, Hart DJ, Byrne J, Harris PA, Dacre JE, Doyle DV. Definition of osteoarthritis of the knee for epidemiological studies. Ann Rheum Dis 1993;52:790-4.
19. McCloskey EV, Spector TD, Eyres KS, Fern ED, O'Rourke N, Vasikaram S, et al. The assessment of vertebral deformity: a method for use in population studies and clinical trials. Osteoporosis Int 1993;3:138-47.
20. Spector TD, McCloskey EV, Doyle DV, Kanis JA. Prevalence of vertebral fracture in women and the relationship with bone density and symptoms: the Chingford Study. J Bone Miner Res 1993;8:817-23.
21. Labib M, Teale D, Marks V. Insulin-like growth factor 1 in patients with hypoglycaemia. Ann Clin Biochem 1990; 27:107-9.
22. Spector TD. The fat on the joint: osteoarthritis and obesity. J Rheumatol 1990;17:283-4.
23. Middleton JF, Tyler JA. Upregulation of insulin-like growth factor I gene expression in the lesions of osteoarthritic human cartilage. Ann Rheum Dis 1992;51:440-7.
24. Bagge E, Eden S, Rosen T, Bengtsson B. The prevalence of radiographic osteoarthritis is low in elderly patients with growth hormone deficiency. Acta Endocrinol 1993; 129:296-300.
25. Johansson AG, Burman P, Westermark K, Ljunghall S. The bone mineral density in acquired growth hormone deficiency correlates with circulating concentrations of insulin-like growth factor 1. J Intern Med 1992;232:447-52.
26. Degerblad M, Elgindy N, Hall K, Sjoberg HE, Thoren M. Potent effect of recombinant growth hormone on bone mineral density and body composition in adults with panhypopituitarism. Acta Endocrinol 1992;126:387-93.
27. Dequeker J, Mohan S, Finkelman RD, Aerssens J, Baylink DJ. Generalised osteoarthritis associated with increased insulin-like growth factor types I and II and transforming growth factor beta in cortical bone from the iliac crest. Arthritis Rheum 1993;36:1702-8.
28. Shimaskai S, Ling N. Identification and molecular characterisation of insulin-like growth factor binding proteins (IGFBP -1, -2, -3, -4, -5 and -6). Prog Growth Factor Res 1991;3:243-66.
29. Manolagas SC, Jilka RL. Bone marrow, cytokines and bone remodelling. N Engl J Med 1995;332:305-11.